BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
March 31, 2014
View Archived Issues
Protein silencing via targeted ubiquitination
Read More
Southwest Research Institute receives contract extension for cyanide antidote
Read More
Merck & Co. licenses NanoBio's adjuvant technology for use in RSV and influenza vaccines
Read More
Novartis presents data for the nAChR partial agonist AQW-051
Read More
Merck & Co. presents preclinical and phase I data for MK-1064
Read More
Scientists at Roche design novel LPA1 receptor antagonists
Read More
VITA contract supports Pulmokine's development of PDGF receptor inhibitor for PAH
Read More
Phase III fertility study of Pergoveris in poor ovarian responders begins
Read More
Halozyme reports topline data from phase I/II study of HTI-501 for cellulite
Read More
Phase II study investigates MLN-0128 for advanced CRPC
Read More
Genentech initiates phase I study of DLYE-5953A for refractory solid tumors
Read More
Phase II study investigates CPX-351 for relapsed/refractory higher risk MDS and AML
Read More
Subcutaneous MabThera approved in Europe for two forms of NHL
Read More
EMA validates MolMed's TK cell/gene therapy submission for conditional approval
Read More
Pivotal phase III Kiobrina study does not meet primary endpoint
Read More
Novel BTK inhibitors patented by Principia Biopharma
Read More
GSK withdraws MAA for combined use of Mekinist and Tafinlar
Read More
BioNumerik Pharmaceuticals divulges new camptothecin analogues
Read More
Neotope Biosciences discloses new anti-MCAM MAbs
Read More
AM-Pharma reports phase I data for recombinant human alkaline phosphatase
Read More
Baxter to create two separate global healthcare companies
Read More
RG-7813 enters first clinical trial for cancer
Read More
FDA committee votes against approval of Novartis's RLX-030 for AHF
Read More
European Commission approves Latuda for schizophrenia
Read More
FDA approves Alprolix for hemophilia B
Read More
TAS-205, a novel H-PGDS inhibitor with promising activity in animal models of allergic rhinitis
Read More
Terbinafine transungual solution active in a phase IIb study
Read More